Back to DYN
TCG Crossover Management, LLC → DYN
TCG Crossover Management, LLC DYN Position History
Dyne Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$74.3M
Q3 2026
Peak value
$102.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $90.3M |
| Q1 2026 | $83.7M |
| Q2 2026 | $102.5M |
| Q3 2026 | $74.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $74.3M | 4.62M | — | — |
| Q2 2026 | $102.5M | 4.62M | — | — |
| Q1 2026 | $83.7M | 4.62M | — | — |
| Q4 2025 | $90.3M | 4.62M | — | — |
Other funds holding DYN
$269.8M
$245.6M
$245.6M
$244.3M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC